Alison M Karst - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alison M Karst

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Cancer Research|December 25, 2013

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancersAlison M Karst, Paul M Jones, Natalie Vena, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT InhibitionGeorge Au-Yeung, Franziska Lang, Walid J Azar, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014

In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogeneGavin P Dunn, Hiu Wing Cheung, Pankaj K Agarwalla, et al.

Cancer Cell|December 17, 2013

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten modelsRuth Perets, Gregory A Wyant, Katherine W Muto, et al.

Science Translational Medicine|August 17, 2012

Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Cancer Research|December 25, 2013

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancersAlison M Karst, Paul M Jones, Natalie Vena, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016

Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT InhibitionGeorge Au-Yeung, Franziska Lang, Walid J Azar, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014

In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogeneGavin P Dunn, Hiu Wing Cheung, Pankaj K Agarwalla, et al.

Cancer Cell|December 17, 2013

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten modelsRuth Perets, Gregory A Wyant, Katherine W Muto, et al.

Science Translational Medicine|August 17, 2012

Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4Yin Ren, Hiu Wing Cheung, Geoffrey von Maltzhan, et al.

Pageof 2